Korro Bio: RNA Editor Plots Way Back After AATD Study Fail - I'm Holding

KRRO-110 miss drives overhaul; KRRO-121/111 show preclinical promise. Click here to read my most recent analysis of the stock ...

Why Promising Lab Drugs Fail: Study Finds How Body Environment Can Flip Drug Effects

Findings published in the journal Nature Structural and Molecular Biology could help explain why drug candidates can look ...
Nasdaq

Altimmune's (ALT) Data From NASH Study Fail to Impress Investors

Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...
BGR

New Study Finds iPhones Fail Far More Often Than Android Phones

Apple customers are generally a shockingly loyal bunch. The company's high repeat customer rate can be attributed to a combination of factors that concern iPhones themselves as well as Apple's ...
Nasdaq

Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both Endpoints

Biohaven Pharmaceuticals BHVN recently announced that the phase II/III HEALY ALS platform study evaluating verdiperstat for treating Amyotrophic Lateral Sclerosis (ALS) failed. ALS is a progressive, ...
UPI

Study: Dietary supplements fail versus prescription drugs with same active ingredient

NEW YORK, Feb. 23 (UPI) --A new study that compares the label accuracy of a generic drug versus a dietary supplement with the same active pharmaceutical ingredient found that the supplement fared very ...